Home > Term: milatuzumab
milatuzumab
A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. Milatuzumab is a type of monoclonal antibody. Also called hLL1 and IMMU-110.
- Μέρος του λόγου: noun
- Κλάδος/Τομέας: Υγεία
- Category: Cancer treatment
- Company: U.S. HHS
0
Δημιουργός
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
